Perioperative assessment and management of patients with valvular heart disease undergoing noncardiac surgery

Minerva Cardioangiologica

Volumn 52, Issue 4, 2004, Pages 255-261

  Bach, D S ^a,b   Eagle, K A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b L3119 Women's 0273 ^*  (United States)

Author keywords

Heart valve diseases; Heart valve prosthesis; Perioperative care

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CEFADROXIL; CEFALEXIN; CLINDAMYCIN; DIGOXIN; FRESH FROZEN PLASMA; GENTAMICIN; HEPARIN; PENICILLIN DERIVATIVE; VANCOMYCIN; VITAMIN K GROUP; WARFARIN;

ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; BACTERIAL ENDOCARDITIS; BJOERK SHILEY VALVE PROSTHESIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CARDIOVERSION; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TOLERANCE; GASTROINTESTINAL SURGERY; HEART DISEASE; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HIP ARTHROPLASTY; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LONG TERM CARE; MITRAL VALVE REGURGITATION; MORBIDITY; PATIENT MONITORING; PENICILLIN ALLERGY; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; QRS COMPLEX; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL RISK; TACHYCARDIA; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; UROLOGIC SURGERY; VALVULAR HEART DISEASE;

ANTICOAGULANTS; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ENDOCARDITIS, BACTERIAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MEDICAL HISTORY TAKING; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; PERIOPERATIVE CARE; PHYSICAL EXAMINATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 4744373929     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Goldman L. Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
2. Detsky AS, Abrams HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986;1:211-9.
3. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990;323:1781-8.
4. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996;27:910-48.
5. Palda VA, Detsky AS. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Int Med 1997;127:315-28.
6. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.
7. Eagle KA, Berger PB, Calkins H, Chairman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery - Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67.
8. Etchells E, Glenns V, Shadowitz S, Bell C, Siu S. A bedside clinical prediction rule for detecting moderate or severe aortic stenosis. J Gen Intern Med 1998;13:699-704.
9. Raymer K, Yang H. Patients with aortic stenosis: cardiac complications in non-cardiac surgery. Can J Anaesth 1998;45:855-9.
10. Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing non-cardiac surgery. Am J Cardiol 1998;81:448-52.
11. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation 1997;96:358-66.
12. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588.
13. Omran H, Hammerstingl C, Schmidt H, von der Recke G, Paar WD, Luderitz B. A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 2003;90:267-71.
14. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003;89:527-30.
15. Todd DW, Roman A. Outpatient use of low-molecular weight heparin in an anticoagulated patient requiring oral surgery: case report. J Oral Maxillofac Surg 2001;59:1090-2.
16. Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000;38:124-6.
17. Berndt N, Khan I, Gallo R. A complication in anticoagulation using low-molecular weight heparin in a patient with a mechanical valve prosthesis; a case report. J Heart Valve Dis 2000;9:844-6.
18. Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000;69:264-5.